Narrow search
Showing 1 - 10 of 161
Cover Image
Will vaccination against rotavirus infection with RIX4414 be cost-saving in Germany?
Knoll, Stefanie; Mair, Christoph; Benter, Ursula; Vouk, … - In: Health economics review 3 (2013) 27, pp. 1-11
immunisation schedule does not currently include rotavirus vaccination. A lack of economic data on the impact of routine … vaccination is stated as one of the reasons. As a result, the current coverage rate is low, around 26%. This study investigated … whether rotavirus vaccination using the two-dose rotavirus vaccine RIX4414 (Rotarix®, GlaxoSmithKline Vaccines) would be a …
Persistent link: https://www.econbiz.de/10010242226
Cover Image
The efficiency of routine infant immunization services in six countries : a comparison of methods
Menzies, Nicolas A.; Suharlim, Christian; Resch, Stephen C. - In: Health economics review 10 (2020) 1, pp. 1-11
Background: Few studies have systematically examined the efficiency of routine infant immunization services. Using a representative sample of infant immunization sites in Benin, Ghana, Honduras, Moldova, Uganda and Zambia (316 total), we estimated average efficiency levels and variation in...
Persistent link: https://www.econbiz.de/10012162671
Cover Image
A reconstruction of a medical history from administrative data : with an application to the cost of skin cancer
Rowell, David; Gordon, Louisa G.; Olsen, Catherine M.; … - In: Health economics review 5 (2015) 4, pp. 1-11
The medical record is a repository of clinical data, which can greatly enhance the quality of health and healthcare analysis. Administrative data are collected for the purpose of billing and reimbursement, and are valued by health researchers because the data are routinely audited to maintain...
Persistent link: https://www.econbiz.de/10010530065
Cover Image
Methodological considerations in cost of illness studies on Alzheimer disease
Costa, Nagede; Derumeaux, Helene; Rapp, Thomas; … - In: Health economics review 2 (2012) 18, pp. 1-12
Cost-of-illness studies (COI) can identify and measure all the costs of a particular disease, including the direct, indirect and intangible dimensions. They are intended to provide estimates about the economic impact of costly disease. Alzheimer disease (AD) is a relevant example to review cost...
Persistent link: https://www.econbiz.de/10009753410
Cover Image
Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain
Blasco, Antonio J.; Lázaro, Pablo; Caballero, Teresa; … - In: Health economics review 3 (2013) 2, pp. 1-11
Background: Icatibant is the only subcutaneous treatment for acute Type I and Type II hereditary angioedema with C1-esterase inhibitor deficiency (HAE-C1-INH) licensed for self-administration in Europe. Aim: To compare the economic impact of two icatibant administration strategies: health...
Persistent link: https://www.econbiz.de/10009755347
Cover Image
Economic burden of multiple sclerosis : a cross-sectional study in Iran
Rezaee, Mehdi; Keshavarz, Khosro; Izadi, Sadegh; … - In: Health economics review 12 (2022) 1, pp. 1-10
Background: Multiple Sclerosis (MS) is a chronic debilitating disease that imposes a heavy socioeconomic burden on societies. This study aimed to determine the economic burden of MS on patients using the first (CinnoVex and ReciGen) and second (Fingolimod and Natalizumab) drug therapy lines....
Persistent link: https://www.econbiz.de/10012804118
Cover Image
Economic burden of lung cancer in Turkey : a cost of illness study from payer perspective
Cicin, Irfan; Oksuz, Ergun; Karadurmus, Nuri; Malhan, Simten - In: Health economics review 11 (2021) 1, pp. 1-12
Background: This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice patterns in clinical practice. Methods: In this cost of illness study, direct medical cost was calculated based on cost items related to...
Persistent link: https://www.econbiz.de/10012588835
Cover Image
Considering the societal perspective in economic evaluations: a systematic review in the case of depression
Duevel, Juliane; Hasemann, Lena; Peña-Longobardo, Luz … - In: Health economics review 10 (2020) 32, pp. 1-19
Background: Depressive disorders are associated with a high burden of disease. However, due to the burden posed by the disease on not only the sufferers, but also on their relatives, there is an ongoing debate about which costs to include and, hence, which perspective should be applied....
Persistent link: https://www.econbiz.de/10012298572
Cover Image
The costs of repatriating an ill seafarer : a micro-costing approach
Faurby, Mads D.; Jensen, Olaf C.; Hjarnoe, Lulu; … - In: Health economics review 7 (2017) 46, pp. 1-8
Seafarers sail the high seas around the globe. In case of illness, they are protected by international regulations stating that the employers must pay all expenses in relation to repatriation, but very little is known about the cost of these repatriations. The objective of this study was to...
Persistent link: https://www.econbiz.de/10011764179
Cover Image
Comparison of the cost of illness of primary liver cancer between Japan and Taiwan
Wu, Yinghui; Matsumoto, Kunichika; Chen, Ya-Mei; Tung, … - In: Health economics review 10 (2020) 38, pp. 1-7
Background: Primary liver cancer (PLC) is the fifth and second leading cause of death in Japan and Taiwan, respectively. The aim of this study was to compare the economic burden of PLC between the two countries using the cost of illness (COI) method and identify the key factors causing the...
Persistent link: https://www.econbiz.de/10012390966